Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPTIBOT: Study Describing the Coverage, Cares and the Fertility of Patients of Less Than 45 Years With a Borderline Ovarian Tumor (BOT)

NCT03690440 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT03690440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03690440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPTIBOT: Study Describing the Coverage, Cares and the Fertility of Patients of Less Than 45 Years With a Borderline Ovarian Tumor (BOT)
Lead sponsor
Institut Curie
Phase
Observational
Overall status
Completed
Start date
June 15, 2018
Completion date
December 31, 2018
Enrollment
176 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

borderline ovarian tumors